These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23033203)

  • 1. [Interventions in people at risk of developing first episode psychosis: a survey of current randomised controlled studies].
    Müller H; Wießmann T; Bechdolf A
    Fortschr Neurol Psychiatr; 2012 Oct; 80(10):570-9. PubMed ID: 23033203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evidence map of interventions across premorbid, ultra-high risk and first episode phases of psychosis.
    Liu P; Parker AG; Hetrick SE; Callahan P; de Silva S; Purcell R
    Schizophr Res; 2010 Oct; 123(1):37-44. PubMed ID: 20558043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups.
    van der Gaag M; Smit F; Bechdolf A; French P; Linszen DH; Yung AR; McGorry P; Cuijpers P
    Schizophr Res; 2013 Sep; 149(1-3):56-62. PubMed ID: 23870806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescents and young adults at ultrahigh risk of psychosis: detection, prediction and treatment. A review of current knowledge.
    Mees L; Zdanowicz N; Reynaert C; Jacques D
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S118-22. PubMed ID: 21894117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal prevention of first psychotic episode through N-acetyl-l-cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo-controlled, parallel-group trial.
    Schmidt SJ; Hurlemann R; Schultz J; Wasserthal S; Kloss C; Maier W; Meyer-Lindenberg A; Hellmich M; Muthesius-Digón A; Pantel T; Wiesner PS; Klosterkötter J; Ruhrmann S;
    Early Interv Psychiatry; 2019 Dec; 13(6):1404-1415. PubMed ID: 30784233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early detection of psychotic disorders].
    Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
    Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
    Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
    Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
    Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
    Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychosis prevention: expectations met].
    Bechdolf A; Peukert R
    Psychiatr Prax; 2011 Feb; 38(2):58-60. PubMed ID: 21394689
    [No Abstract]   [Full Text] [Related]  

  • 13. Early interventions to prevent psychosis: systematic review and meta-analysis.
    Stafford MR; Jackson H; Mayo-Wilson E; Morrison AP; Kendall T
    BMJ; 2013 Jan; 346():f185. PubMed ID: 23335473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.
    Morrison AP; French P; Parker S; Roberts M; Stevens H; Bentall RP; Lewis SW
    Schizophr Bull; 2007 May; 33(3):682-7. PubMed ID: 16973786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian Ultra High Risk study.
    Joa I; Gisselgård J; Brønnick K; McGlashan T; Johannessen JO
    BMC Psychiatry; 2015 Apr; 15():89. PubMed ID: 25897797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specialised first-episode psychosis services: a systematic review of the literature].
    Skalli L; Nicole L
    Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin and dopamine interactions in psychosis prevention.
    Richtand NM; McNamara RK
    Prog Brain Res; 2008; 172():141-53. PubMed ID: 18772031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early intervention in patients at ultra high risk of psychosis: benefits and risks.
    de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH
    Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness.
    Preti A; Cella M
    Schizophr Res; 2010 Oct; 123(1):30-6. PubMed ID: 20727717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?
    Mossaheb N; Schäfer MR; Schlögelhofer M; Klier CM; Cotton SM; McGorry PD; Amminger GP
    Schizophr Res; 2013 Aug; 148(1-3):163-7. PubMed ID: 23778032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.